Sequenom Stock Hits New 52-Week Low (SQNM)

NEW YORK ( TheStreet) -- Sequenom (Nasdaq: SQNM) hit a new 52-week low Monday as it is currently trading at $3.50, below its previous 52-week low of $3.52 with 520,865 shares traded as of 10:05 a.m. ET. Average volume has been 3.9 million shares over the past 30 days.

Sequenom has a market cap of $438.7 million and is part of the health care sector and drugs industry. Shares are down 20% year to date as of the close of trading on Friday.

Sequenom, Inc. provides products, services, diagnostic testing, applications, and genetic analysis products that translate the results of genomic science into solutions for biomedical research, translational research, molecular medicine applications, and agricultural and livestock research.

TheStreet Ratings rates Sequenom as a sell. The company's weaknesses can be seen in multiple areas, such as its unimpressive growth in net income, weak operating cash flow, generally disappointing historical performance in the stock itself and feeble growth in its earnings per share. You can view the full Sequenom Ratings Report.

See all 52-week low stocks or get investment ideas from our investment research center.

If you liked this article you might like

These 5 Stocks Under $10 Are Set to Soar Higher

Insider Trading Alert - KSU, TLMR And SQNM Traded By Insiders

Sophiris Bio Tops Dollar-Stock Gainers on Trial Success of Cancer Treatment

Sophiris Bio Tops Dollar-Stock Gainers on Trial Success of Cancer Treatment

Insider Trading Alert - SQNM, OFIX And CIEN Traded By Insiders

5 Stocks Insiders Love for 2016